nach oben

Indian Journal of Gastroenterology

Erschienen in:

01.09.2012 | Short Report

Safety and efficacy of therapeutic endoscopic interventions in the management of biliary leak

verfasst von: Atul Sachdev, Jeet Ram Kashyap, Sanjay D’Cruz, Divyanshoo R. Kohli, Ram Singh, Kamal Singh

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Endoscopic procedures which reduce the trans-papillary pressure gradient are the treatment of choice for management of biliary leaks. We analyzed the data of 102 patients with biliary leak managed by various endoscopic procedures like endoscopic sphincterotomy (ES), ES with stenting, stenting alone or nasobiliary drainage (NBD) alone; 90 of these patients had developed a leak after cholecystectomy. In the post-cholecystectomy group, cannulation was successful in 79 patients; therapeutic intervention was not possible in 14 of them due to complete transection of common bile duct in 6, and leak proximal to ligature in 8. In the remaining 65 patients, ES with stenting was done in 52, stent alone in 6, ES alone in 5 and NBD alone in 2. All 12 patients in other etiology group were treated with ES plus stenting. The leak closed in a mean of 3 (1–10) days in all patients. Stents were removed after 6–8 weeks. Endoscopic procedures are effective in managing biliary leaks.

Schlumpf R, Klotz HP, Wehrli H, Herzog U. A nation’s experience in laparoscopic cholecystectomy. Prospective multicenter analysis of 3722 cases. Surg Endosc. 1994;8:35–41.PubMedCrossRef

Khan MH, Howard TJ, Fogel EL, et al. Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center. Gastrointest Endosc. 2007;65:247–52.PubMedCrossRef

Scott TR, Zucker KA, Bailey RW. Laparoscopic cholecystectomy: a review of 12,397 patients. Surg Laparosc Endosc. 1992;2:191–8.PubMed

Qin YS, Li ZS, Sun ZX, Wu RP, Wang N, Yao YZ. Endoscopic management of biliary complications after orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int. 2006;5:39–42.PubMed

Morgenstern L, McGrath MF, Carroll BJ, Paz-Partlow M, Berci G. Continuing hazards of the learning curve in laparoscopic cholecystectomy. Am Surg. 1995;61:914–8.PubMed

Ryan ME, Geenen JE, Lehman GA, et al. Endoscopic intervention for biliary leaks after laparoscopic cholecystectomy: a multicenter review. Gastrointest Endosc. 1998;47:261–6.PubMedCrossRef

Al Karawi MA, Sanai FM, Mohamed Ael S, Mohamed SA. Endoscopic management of postcholecystectomy bile duct injuries: review. Saudi J Gastroenterol. 2000;6:67–78.PubMed

Browder IW, Dowling JB, Koontz KK, Litwin MS. Early management of operative injuries of the extrahepatic biliary tract. Ann Surg. 1987;205:649–58.PubMedCrossRef

Lillemoe KD. Benign post-operative bile duct strictures. Baillieres Clin Gastroenterol. 1997;11:749–79.PubMedCrossRef

10.

Bridges A, Wilcox CM, Varadarajulu S. Endoscopic management of traumatic bile leaks. Gastrointest Endosc. 2007;65:1081–5.PubMedCrossRef

11.

Shah JN. Endoscopic treatment of bile leaks: current standards and recent innovations. Gastrointest Endosc. 2007;65:1069–72.PubMedCrossRef

12.

Pawa S, Al-Kawas FH. ERCP in the management of biliary complications after cholecystectomy. Curr Gastroenterol Rep. 2009;11:160–6.PubMedCrossRef

13.

Donnellan F, Zeb F, Courtney G, Aftab AR. Successful outcome of sphincterotomy and 7 French pigtail stent insertion in the management of post-cholecystectomy bile leaks. Hepatobiliary Pancreat Dis Int. 2009;8:309–11.PubMed

14.

Katsinelos P, Kountouras J, Paroutoglou G, et al. A comparative study of 10-Fr vs. 7-Fr straight plastic stents in the treatment of postcholecystectomy bile leak. Surg Endosc. 2008;22:101–6.PubMedCrossRef

15.

Kaffes AJ, Hourigan L, De Luca N, Byth K, Williams SJ, Bourke MJ. Impact of endoscopic intervention in 100 patients with suspected postcholecystectomy bile leak. Gastrointest Endosc. 2005;61:269–75.PubMedCrossRef

16.

Mavrogiannis C, Liatsos C, Papanikolaou IS, Karagiannis S, Galanis P, Romanos A. Biliary stenting alone versus biliary stenting plus sphincterotomy for the treatment of post-laparoscopic cholecystectomy biliary leaks: a prospective randomized study. Eur J Gastroenterol Hepatol. 2006;18:405–9.PubMedCrossRef

17.

Agarwal N, Sharma BC, Garg S, Kumar R, Sarin SK. Endoscopic management of postoperative bile leaks. Hepatobiliary Pancreat Dis Int. 2006;5:273–7.PubMed

18.

Pinkas H, Brady PG. Biliary leaks after laparoscopic cholecystectomy: time to stent or time to drain. Hepatobiliary Pancreat Dis Int. 2008;7:628–32.PubMed

19.

Cote GA, Ansstas M, Shah S, et al. Findings at endoscopic retrograde cholangiopancreatography after endoscopic treatment of postcholecystectomy bile leaks. Surg Endosc. 2010;24:1752–6.PubMedCrossRef

20.

Salih M, Hamid S, Shah HA, Abbas Z, Jafri W. Endoscopic management of biliary leaks after open and laparoscopic cholecystectomy. J Pak Med Assoc. 2007;57:117–9.PubMed

21.

Sandha GS, Bourke MJ, Haber GB, Kortan PP. Endoscopic therapy for bile leak based on a new classification: results in 207 patients. Gastrointest Endosc. 2004;4:567–74.CrossRef

22.

Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909–18.PubMedCrossRef

23.

Freeman ML. Complications of endoscopic sphincterotomy. Endoscopy. 1998;30:A216–20.

Titel: Safety and efficacy of therapeutic endoscopic interventions in the management of biliary leak
verfasst von: Atul Sachdev
Jeet Ram Kashyap
Sanjay D’Cruz
Divyanshoo R. Kohli
Ram Singh
Kamal Singh
Publikationsdatum: 01.09.2012
Verlag: Springer-Verlag
Erschienen in: Indian Journal of Gastroenterology / Ausgabe 5/2012
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI: https://doi.org/10.1007/s12664-012-0209-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2012

Audit of patients with severe acute pancreatitis admitted to an intensive care unit

Spontaneous regression of hepatocellular carcinoma

Intestinal transplantation: a review

Hepatitis C in Punjab—Peeping into Pandora’s box!

Non-organ-specific autoantibodies in Indian patients with chronic liver disease

Acute abdomen in a septuagenarian